James Hattersley
Corporate Officer/Principal presso PALATIN TECHNOLOGIES, INC.
Profilo
James E.
Hattersley is currently a Director at Temple Therapeutics BV and a Senior Vice President-Business Development at Palatin Technologies, Inc. He was previously a Vice President-Business Development at Nektar Therapeutics from 2014 to 2015, a Vice President-Business Development at Antares Pharma, Inc., and a Vice President-Business Development at Sun Pharmaceutical Industries, Inc. from 2008 to 2014.
He also served as a Senior Vice President-Business Development at Adherium Ltd.
Mr. Hattersley received his undergraduate degree from the University of California and his graduate degree from The University of Chicago Booth School of Business.
Posizioni attive di James Hattersley
Società | Posizione | Inizio |
---|---|---|
PALATIN TECHNOLOGIES, INC. | Corporate Officer/Principal | 28/06/2021 |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di James Hattersley
Società | Posizione | Fine |
---|---|---|
NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/12/2015 |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Sun Pharmaceutical Industries, Inc. provides pharmaceutical products. Its products include petrochemical, drugs, vaccines and fertilizers. The company is headquartered in Cranbury, NJ. | Corporate Officer/Principal | 01/05/2014 |
ADHERIUM LIMITED | Corporate Officer/Principal | - |
ANTARES PHARMA, INC. | Corporate Officer/Principal | - |
Formazione di James Hattersley
University of California | Undergraduate Degree |
The University of Chicago Booth School of Business | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
ADHERIUM LIMITED | Health Technology |
PALATIN TECHNOLOGIES, INC. | Health Technology |
Aziende private | 3 |
---|---|
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Sun Pharmaceutical Industries, Inc. provides pharmaceutical products. Its products include petrochemical, drugs, vaccines and fertilizers. The company is headquartered in Cranbury, NJ. | Health Technology |
Temple Therapeutics BV
Temple Therapeutics BV BiotechnologyHealth Technology Temple Therapeutics BV is a Dutch company that focuses on developing treatments and early detection diagnostics for tissue fibrosis, endometriosis, and ovarian cancer. Temple Therapeutics is based in Geleen, NL. The private company uses scientific innovations and a novel cellular metabolism approach to create a pipeline of highly differentiated diagnostic and drug candidates. The company prioritizes women's healthcare and aims to provide life-changing innovations. The company was founded in 2015, and the CEO is Sanj Singh. | Health Technology |
- Borsa valori
- Insiders
- James Hattersley